drugset

drugset / Trial / NCT00806494

UK Study Assessing Flexible Dose Fesoterodine in Adults

NCT00806494 ↗

Phase 4 Completed 331 enrolled Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To explore the effects of fesoterodine when used in a flexible dose manner

Timeline

Start: 2009-02
Primary completion: 2010-01
Completion: 2010-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Fesoterodine	Other / unclassified	8 mg	—

Indications